Abstract
Electrolyte imbalances are common in patients with cancer. They may arise from tumor- or treatment-related factors or other causes. These imbalances can lead to life-threatening oncologic emergencies, such as tumor lysis syndrome, syndrome of inappropriate antidiuretic hormone secretion, and hypercalcemia of malignancy. Early recognition and management are crucial to prevent serious complications and improve patient outcomes. Advanced practice providers must be aware of the symptoms in order to incorporate preventive measures and manage these abnormalities appropriately. This article will review the current evidence-based literature on electrolyte abnormalities and emergencies associated with electrolytes in the care of oncology patients.
References
Berardi, R., Torniai, M., Lenci, E., Pecci, F., Morgese, F., & Rinaldi, S. (2019). Electrolyte disorders in cancer patients: A systematic review. Journal of Cancer Metastasis and Treatment, 5(79). https://doi.org/10.20517/2394-4722.2019.008
Cairo, M. S., & Bishop, M. (2004). Tumor lysis syndrome: New therapeutic strategies and classification. British Journal of Haematology, 127(1), 3–11. https://doi.org/10.1111/j.1365-2141.2004.05094.x
Coiffier, B., Altman, A., Pui, C.-H., Younes, A., & Cairo, M. S. (2008). Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review. Journal of Clinical Oncology, 26(16), 2767–2778. https://doi.org/10.1200/JCO.2007.15.0177
Espinoza-Munoz, S., Flores-Henriquez, I., & Soto-Munizaga, R. (2023). Recommendations for the management of hypokalemia in patients with cancer. Medwave, 23(05), e2669. https://doi.org/10.5867/medwave.2023.05.2669
Feldenzer, K. L., & Sarno, J. (2018). Hypercalcemia of malignancy. Journal of the Advanced Practitioner in Oncology, 9(5), 496–504. https://doi.org/10.6004/jadpro.2018.9.5.4
Findakly, D., Luther, R. D., 3rd, & Wang, J. (2020). Tumor lysis syndrome in solid tumors: A comprehensive literature review, new insights, and novel strategies to improve outcomes. Cureus, 12(5), e8355. https://doi.org/10.7759/cureus.8355
Ganesan, K., Goyal, A., & Roane, D. (2023). Bisphosphonate. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470248/
Guise, T. A., & Wysolmerski, J. J. (2022). Cancer-associated hypercalcemia. The New England Journal of Medicine, 386(15), 1443–1451. https://doi.org/10.1056/NEJMcp2113128
Gujarathi, R., Chippa, V., Candula, N., & Kadakia, M. (2022). Pseudohyperkalemia in a patient with chronic lymphocytic leukemia. Cureus, 14(3), e23512. https://doi.org/10.7759/cureus.23512
Higdon, M. L., Atkinson, C. J., & Lawrence, K. V. (2018). Oncologic emergencies: Recognition and initial management. American Family Physician, 97(11), 741–748. https://www.aafp.org/pubs/afp/issues/2018/0601/p741.html
Jordan, B., Jahn, F., Beckmann, J., Unverzagt, S., Muller-Tidow, C., & Jordan, K. (2016). Calcium and magnesium infusions for the prevention of oxaliplatin-induced peripheral neurotoxicity: A systematic review. Oncology, 90, 299–306. https://doi.org/10.1159/000445977
Kearney, D., Reisinger, N., & Lohani, S. (2022). Integrative volume status assessment. POCUS Journal, 7(Kidney), 65–77. https://doi.org/10.24908/pocus.v7iKidney.15023
Kim, G. H. (2022). Pathophysiology of drug-induced hyponatremia. Journal of Clinical Medicine, 11(19), 5810. https://doi.org/10.3390/jcm11195810
Klemencic, S., & Perkins, J. (2019). Diagnosis and management of oncologic emergencies. Western Journal of Emergency Medicine, 20(2), 316–322. https://doi.org/10.5811/westjem.2018.12.37335
McBride, A., Trifilio, S., Baxter, N., Gregory, T. K., & Howard, S. C. (2017). Managing tumor lysis syndrome in the era of novel cancer therapies. Journal of the Advanced Practitioner in Oncology, 8(7), 705–720. https://doi.org/10.6004/jadpro.2017.8.7.4
Naseer, M., Kania, B., Ghrewati, M., Mahmoud, A., Faheem, B., & Singhal, M. (2023). Rare case of refractory hypokalemia in a patient with acute monocytic leukemia. The American Journal of Case Reports, 24, e938775. https://doi.org/10.12659/AJCR.938775
Puri, I., Sharma, D., Gunturu, K. S., & Ahmed, A. A. (2020). Diagnosis and management of tumor lysis syndrome. Journal of Community Hospital Internal Medicine Perspectives, 10(3), 268–272. https://doi.org/10.1080/20009666.2020.1761185
Rosner, M. H., & Dalkin, A. C. (2014). Electrolyte disorders associated with cancer. Advances in Chronic Kidney Disease, 21(1), 7–17. https://doi.org/10.1053/j.ackd.2013.05.005
Sadiq, N. M., Naganathan, S., & Badireddy, M. (2023). Hypercalcemia. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430714/
Tenma, K., et al. (2019). Syndrome of inappropriate antidiuretic hormone secretion in small-cell lung cancer. Case Reports in Oncology, 12(3), 813-819.
Thandra, K., Salah, Z., & Chawla, S. (2018). Oncologic emergencies—The old, the new, and the deadly. Journal of Intensive Care Medicine, 35(1), 3–13. https://doi.org/10.1177/0885066618803863
Turcotte, A., Achi, S., Mamlouk, O., & Mandayam, S. (2022). Electrolyte disturbances in cancer patients. Current Opinion in Nephrology and Hypertension, 31(5), 425–434. https://doi.org/10.1097/MNH.0000000000000819
Verzicco, I., Regolisti, G., Quaini, F., Bocchi, P., Brusasco, I., Ferrari, M.,…Cabassi, A. (2020). Electrolyte disorders induced by antineoplastic drugs. Frontiers in Oncology, 10, 779. https://doi.org/10.3389/fonc.2020.00779
Workeneh, B. T., Uppal, N. N., Jhaveri, K. D., & Rondon-Berrios, H. (2021). Hypomagnesemia in the cancer patient. Kidney360, 2(1), 154-166. https://doi.org/10.34067/KID.0005622020
